Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
NCT00453375
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Hypoglycemia
Interventions
DRUG:
BHT-3021
DRUG:
BHT-Placebo
Sponsor
Bayhill Therapeutics